Stifel resumed coverage of Alphatec (ATEC) with a Buy rating and $20 price target Alphatec stood out in the firm’s U.S. spine surgeon survey as the fastest expected share gainer, giving the firm confidence in the company’s “beat-and-raise playbook,” the analyst tells investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATEC: